3 Dividend Stocks to Hold for the Long Haul: Merck and Bristol-Myers
The article spotlights Merck (MRK) and Bristol-Myers Squibb (BMY) as top dividend stocks for long-term investors, citing their consistent history of raising payouts.
According to a report from Motley Fool, investors seeking steady long-term income are advised to hold dividend stocks like Merck (MRK) and Bristol-Myers Squibb (BMY). These companies have a strong track record of consistently increasing their dividend payouts, providing growing cash flow to shareholders.
Why Dividend Stocks Are Attractive
Dividend stocks are appealing for investors looking for consistent income, especially during market volatility. Companies that regularly raise dividends often have strong fundamentals and stable cash flows.
Merck (MRK)
Merck & Co. (ticker: MRK) is one of the world's largest pharmaceutical companies. It has a long history of paying and increasing dividends, making it a favorite for income-focused investors. Merck's strong product portfolio includes cancer treatments and vaccines.
Bristol-Myers Squibb (BMY)
Bristol-Myers Squibb (ticker: BMY) is another pharmaceutical company known for its stable dividends. The company focuses on developing innovative therapies in areas like oncology and immunology. BMY's dividend growth record reflects its financial strength.
What This Means for Investors
For long-term investors, stocks like MRK and BMY can provide stable income and potential growth. However, risks in the healthcare sector, such as regulatory changes and patent expirations, should be considered.
Frequently Asked Questions
Found this useful? Share it